GlaxoSmithKline (United States)

Electronic health records to facilitate clinical research

Martín Cowie, Juuso Blomster, Lesley H. Curtis et al.

2016 · 656 Zit.

Artificial Intelligence and Pharmacometrics: Time to Embrace, Capitalize, and Advance?

Ayyappa Chaturvedula, Stacie Calad-Thomson, Chao Liu et al.

2019 · 40 Zit.

Study design and baseline characteristics of patients on dialysis in the ASCEND-D trial

Ajay Singh, Allison Blackorby, Borut Čižman et al.

2021 · 17 Zit.

Use of Response Permutation to Measure an Imaging Dataset’s Susceptibility to Overfitting by Selected Standard Analysis Pipelines

Jayasree Chakraborty, Abhishek Midya, Brenda F. Kurland et al.

2024 · 4 Zit.

Potential Meets Practicality: <scp>AI</scp>'s Current Impact on the Evidence Generation and Synthesis Pipeline in Health Economics

Nichola R. Naylor, Noemi Hummel, Carl de Moor et al.

2025 · 2 Zit.

RWD55 Deep Real-World Analysis of Patients With Myelofibrosis Using Natural Language Processing and Machine Learning: A Methods Description

Fulya Sen Nikitas, Tim d'Estrube, Bond Vo et al.

2025 · 0 Zit.

Corrigendum: An industry perspective on the use of machine learning in drug and vaccine safety

Jeffery L. Painter, Raymond Kassekert, Andrew Bate

2023 · 0 Zit.